Results 1 to 10 of about 58,502 (304)

Erythema dyschromicum perstans (ashy dermatosis) during the treatment with infliximab in a child with Crohn disease

open access: yesPrzegląd Dermatologiczny, 2014
Introduction . Erythema dyschromicum perstans (EDP) or ashy dermatosis is a rare, benign acquired disease characterized by macular hyperpigmentations.
Michał Sobjanek   +4 more
doaj   +1 more source

The role of hypothalamus-pituitary-adrenal (HPA)-like axis in inflammatory pilosebaceous disorders [PDF]

open access: yes, 2020
Skin is the largest peripheral endocrine organ and functions as a hormone target and endocrine gland. A cutaneous hypothalamus-pituitary-adrenal (HPA)-like axis enables the skin to respond to stress and regulates its steroidogenic activity.
Clark, Ashley K   +3 more
core  

NOD2 and inflammation: current insights [PDF]

open access: yes, 2018
The nucleotide-binding oligomerization domain (NOD) protein, NOD2, belonging to the intracellular NOD-like receptor family, detects conserved motifs in bacterial peptidoglycan and promotes their clearance through activation of a proinflammatory ...
Cucchiara, Salvatore   +3 more
core   +2 more sources

Ambulatory surgery for perianal Crohn’s disease. Study of feasibility [PDF]

open access: yes, 2018
Background. One-third of Crohn’s disease (CD) patients present perianal fistula. The gold standard in the diagnosis and treatment of symptomatic perianal disease (PAD) in CD is the exploration of the anal canal and distal rectum under anesthesia (EUA ...
Arcudi, C.   +10 more
core   +2 more sources

The PRECiSE 2 trial of certolizumab pegol, a new PEGylated anti-TNF agent, in the treatment of Crohn's disease - An interview with David A Schwartz, 13 June 2007

open access: yesBiologics: Targets & Therapy, 2008
David A SchwartzVanderbilt University Medical Center, Nashville, TN, USAContext: Certolizumab pegol (CDP 870) is a new anti-tumor necrosis factor (TNF) therapy currently in development for the treatment of Crohn’s disease, rheumatoid arthritis,
David A Schwartz
doaj  

Introduction to and Screening Visit Results of the Multicenter Pediatric Crohn's Disease Growth Study. [PDF]

open access: yes, 2020
BackgroundStatural growth impairment is more common in males with Crohn's disease (CD). We assessed sex differences in height Z score differences and bone age (BA) Z scores and characterized age of menarche in a novel contemporary cohort of pediatric CD ...
Andrews, Howard   +9 more
core  

Distinguishing tuberculosis and Crohn′s disease in developing countries: How certain can you be of the diagnosis?

open access: yesThe Saudi Journal of Gastroenterology, 2009
Distinguishing tuberculosis and Crohn′s disease in patients presenting with chronic abdominal pain and diarrhea is a huge diagnostic challenge, particularly in tuberculosis endemic countries.
Navaneethan Udayakumar   +3 more
doaj  

Diagnosis of regional enrteritis (Crohn disease)

open access: yesThe Saudi Journal of Gastroenterology, 2003
Regional enteritis (Crohn disease) may present a diagnostic problem that needs to be solved by clinicians practicing in areas known to be endemic for tuberculosis.
Khalil Mohamed
doaj  

Clinical features of nonspecific ulcerative colitis and Crohn's disease in children [PDF]

open access: yesСаратовский научно-медицинский журнал, 2010
The article presents the data of age, manifestation, localization and clinical features of course of Crohn's disease and nonspecific ulcerative colitis.
Malakhinova N.A.
doaj  

Simultaneous central retinal artery occlusion and optic nerve vasculitis in Crohn disease

open access: yesAmerican Journal of Ophthalmology Case Reports, 2017
Purpose: To describe a case of Crohn disease presenting as occlusive vasculitis resulting in a central retinal artery occlusion (CRAO) in one eye and transient ischemic optic neuropathy in the fellow eye.
Razek Georges Coussa   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy